Ernexa Therapeutics Inc.: Form 8-K, filed Apr 23, 2021
Filed with the SEC on Apr 23, 2021 and accepted by EDGAR at Apr 23, 2021, 17:20 ET.
Items reported
- Item 4.01 Change of auditor
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001140361-21-014148. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.